FDC
Quarterly Results Analysis [Sep2026]
FDC Quarterly Results
| Consolidated | Sep2026 UnAudited |
Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 Audited |
Dec2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹572 Cr | ₹668 Cr | ₹585 Cr | ₹465 Cr | ₹473 Cr | ₹648 Cr | ₹492 Cr | ₹464 Cr |
| Expenses | ₹508 Cr | ₹525 Cr | ₹478 Cr | ₹412 Cr | ₹439 Cr | ₹508 Cr | ₹438 Cr | ₹417 Cr |
| Operating Income | ₹64 Cr | ₹143 Cr | ₹106 Cr | ₹52 Cr | ₹34 Cr | ₹140 Cr | ₹54 Cr | ₹47 Cr |
| Other Income | ₹18 Cr | ₹48 Cr | ₹50 Cr | ₹21 Cr | ₹21 Cr | ₹36 Cr | ₹16 Cr | ₹19 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹16 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr |
| Profit Before Tax | ₹65 Cr | ₹175 Cr | ₹140 Cr | ₹36 Cr | ₹38 Cr | ₹160 Cr | ₹53 Cr | ₹51 Cr |
| Profit After Tax | ₹49 Cr | ₹132 Cr | ₹103 Cr | ₹28 Cr | ₹28 Cr | ₹121 Cr | ₹39 Cr | ₹37 Cr |
| EPS | ₹3.01 | ₹8.14 | ₹6.35 | ₹1.74 | ₹1.74 | ₹7.45 | ₹2.38 | ₹2.28 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | 11.3% | 10% | -13.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.1% | -4.2% | 4.1% |
| DIVIS LABORATORIES | 7.5% | 1.3% | 45.7% |
| TORRENT PHARMACEUTICALS | 1.8% | -6.3% | 26.1% |
| CIPLA | 1.5% | -2.3% | -17.3% |
| DR REDDYS LABORATORIES | 9.3% | 9.5% | 4.3% |
| MANKIND PHARMA | 11% | 0.9% | 1.4% |
| LUPIN | 3.8% | -3.1% | 1.6% |
| ZYDUS LIFESCIENCES | 5.2% | -2.2% | 16.3% |
FDC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -14.31 % |
| Y-o-Y | 20.95 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2026 | ₹572 Cr | -14.31 | |
| Jun2026 | ₹668 Cr | 14.18 | |
| Mar2026 | ₹585 Cr | 25.84 | |
| Dec2025 | ₹465 Cr | -1.76 | |
| Sep2025 | ₹473 Cr | -27.05 | |
| Jun2025 | ₹648 Cr | 31.82 | |
| Mar2025 | ₹492 Cr | 5.98 | |
| Dec2024 | ₹464 Cr | - | |
FDC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -55.04 % |
| Y-o-Y | 90.15 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2026 | ₹64 Cr | -55.04 | |
| Jun2026 | ₹143 Cr | 34.45 | |
| Mar2026 | ₹106 Cr | 103.45 | |
| Dec2025 | ₹52 Cr | 54.63 | |
| Sep2025 | ₹34 Cr | -75.91 | |
| Jun2025 | ₹140 Cr | 160.01 | |
| Mar2025 | ₹54 Cr | 15.71 | |
| Dec2024 | ₹47 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -47.53 % |
| Y-o-Y | 57.20 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2026 | 11.24% | -47.53 | |
| Jun2026 | 21.42% | 17.76 | |
| Mar2026 | 18.19% | 61.69 | |
| Dec2025 | 11.25% | 57.34 | |
| Sep2025 | 7.15% | -66.97 | |
| Jun2025 | 21.65% | 97.36 | |
| Mar2025 | 10.97% | 9.15 | |
| Dec2024 | 10.05% | - | |
FDC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -62.97 % |
| Y-o-Y | 72.93 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2026 | ₹49 Cr | -62.97 | |
| Jun2026 | ₹132 Cr | 28.14 | |
| Mar2026 | ₹103 Cr | 265.33 | |
| Dec2025 | ₹28 Cr | -0.24 | |
| Sep2025 | ₹28 Cr | -76.62 | |
| Jun2025 | ₹121 Cr | 213.81 | |
| Mar2025 | ₹39 Cr | 4.40 | |
| Dec2024 | ₹37 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -56.80 % |
| Y-o-Y | 42.83 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2026 | 8.57 % | -56.80 | |
| Jun2026 | 19.84 % | 12.22 | |
| Mar2026 | 17.68 % | 190.31 | |
| Dec2025 | 6.09 % | 1.50 | |
| Sep2025 | 6 % | -67.95 | |
| Jun2025 | 18.72 % | 138.17 | |
| Mar2025 | 7.86 % | -1.50 | |
| Dec2024 | 7.98 % | - | |
FDC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -63.02 % |
| Y-o-Y | 72.99 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2026 | ₹3.01 | -63.02 | |
| Jun2026 | ₹8.14 | 28.19 | |
| Mar2026 | ₹6.35 | 264.94 | |
| Dec2025 | ₹1.74 | 0.00 | |
| Sep2025 | ₹1.74 | -76.64 | |
| Jun2025 | ₹7.45 | 213.03 | |
| Mar2025 | ₹2.38 | 4.39 | |
| Dec2024 | ₹2.28 | - | |
You may also like the below Video Courses